Sulfonyl aryl or heteroaryl hydroxamic acid compounds
US7115632B1 · kind B1 · utility
22Cited by
15References
55Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 11, 2000 |
| Grant date | Oct 3, 2006 |
| Priority date | — |
| Expiry date | May 11, 2020 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D295/26
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
A sulfonyl aromatic or heteroaromatic ring hydroxamic acid compound that inter alia inhibits matrix metalloprotease activity is disclosed as are a treatment process that comprises administering a contemplated sulfonyl aromatic or heteroaromatic ring hydroxamic acid compound in a MMP enzyme-inhibiting effective amount to a host having a condition associated with pathological matrix metalloprotease activity. A contemplated compound corresponds in structure to the formulawherein W and the R groups are defined elsewhere.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.